Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders

HIV Medicine

Volumn 7, Issue 4, 2006, Pages 205-212

  Mijch, Anne M ^a,b,c   Burgess, P ^d   Judd, F ^a,c   Grech, P ^a,e   Komiti, A ^a,c,e   Hoy, J ^a,b,c,f   Lloyd, J H ^a,f   Gibbie, T ^b   Street, A ^a,f  

^a Victorian HIV Psychiatry Consortium   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

AIDS; HIV; Hospitalizations; Mental health; Schizophrenia; Survival

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; ARTICLE; AUSTRALIA; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DRUG USE; EXPOSURE; FEMALE; FREQUENCY ANALYSIS; GENDER; HEALTH CARE UTILIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; MENTAL DISEASE; MENTAL HEALTH SERVICE; MOOD DISORDER; MORTALITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHIZOPHRENIA; SUBSTANCE ABUSE; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX DISTRIBUTION; SUBSTANCE-RELATED DISORDERS; SURVIVAL ANALYSIS; VICTORIA;

EID: 33645464670     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2006.00359.x     Document Type: Article

References (23)

1. Lyketsos CG, Hutton H, Fishman M et al. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS 1996; 10: 1033-1039.
2. Cournos F, McKinnon K. HIV seroprevalence among people with severe mental illness in the United States: A critical review. Clin Psychol Rev 1997; 17: 259-269.
3. Rosenberger PH, Bornstein RA, Nasrallah HA et al. Psychopathology in human immunodeficiency virus infection: Lifetime and current assessment. Comp Psychiatry 1993; 34: 150-158.
4. Misdrahi D, Vila G, Funk-Brentano I, Tardieu M, Blanche S, Mouren-Simeoni MC. DSM-IV mental disorders and neurological complications in children and adolescents with human immunodeficiency virus type 1 infection (HIV-1). Eur Psychiatry 2004; 19: 182-184.
5. Chan KS, Orlando M, Joyce G et al. Combination antiretroviral therapy and improvements in mental health: Results from a nationally representative sample of persons undergoing care for HIV in the United States. J Acquir Immune Defic Syndr 2003; 33: 104-111.
6. Judd FK, Cockram AM, Komiti A et al. Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: A longitudinal study. Aust NZ J Psychiatry 2000; 34: 1015-1021.
7. Blanch JCB, Garcia F, Parellada E et al. Manic syndrome associated with efavirenz overdose. Clin Infect Dis 2001; 33: 270-271.
8. Gazzard BG. Efavirenz in the management of HIV infection. Int J Clin Pract 1999; 53: 60-64.
9. Angelino AF. Management of psychiatric disorders in patients infected with human immunodeficiency virus. Clin Infect Dis 2001; 33: 847-856.
10. Gifford AL, Bormann JE, Shively MJ. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000; 23: 386-395.
11. Ickovics JR, Hamburger ME, Vlahov D et al. For the HIV Epidemiology Research Study Group. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. J Am Med Assoc 2001; 285: 1466-1474.
12. NCHECR. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report 2001. Sydney, Australia: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 2001.
13. Thompson S, Checkley GE, Hocking J et al. HIV risk behaviour and HIV testing of psychiatric patients in Melbourne. Aust NZ J Psychiatry 1997; 31: 566-576.
14. Davidson S, Judd F, Jolley D, Hocking B, Thompson S, Hyland B. Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill. Aust NZ J Psychiatry 2001; 35: 203-209.
15. Kelly B, Rapheal B, Judd F et al. Psychiatric disorder in HIV infection. Aust NZ J Psychiatry 1998; 32: 441-453.
16. Mijch AM, Hoy J, Watson K et al. Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years? J Clin Virol 2001; 22: 271 -278.
17. Burgess PM, Joyce C, Pattison PE. Social indicators in the prediction of psychiatric inpatient service utilisation. Social Psychiatry Psychiatric Epidemiol 1992; 27: 83-94.
18. Eaton WW, Moretensen P, Herrman H. Long term hospitalisation for schizophrenia. Schizophrenia Bull 1992; 18: 217-228.
19. Krupinski J, Alexander L, Carson N. Patterns of Psychiatric Care in Victoria. Melbourne, Australia: Health Commission of Victoria, 1982.
20. Bing EG, Burnam MA, Longshore D et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001; 58: 721-728.
21. Himelhoch S, Moore RD, Treisman G, Gebo KA. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr 2004; 37: 1457-1463.
22. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001; 158: 725-730.
23. Marzolini C, Telenti A, Decosterd LA et al. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS 2001; 15: 71-75.